CVS HEALTH CORPORATION Debt Securities, Available-for-sale, Realized Loss
CVS HEALTH CORPORATION (CVS) reported Debt Securities, Available-for-sale, Realized Loss of $23.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss · last filed 2026-08-05
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized loss for the quarter ending 2026-06-30 was $23.00M, a 52.08% decline year-over-year.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized loss for the quarter ending 2026-03-31 was $28.00M, a 28.21% decline year-over-year.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized loss for the quarter ending 2025-12-31 was -$245.00M.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized loss for the quarter ending 2025-09-30 was $27.00M, a 30.77% decline year-over-year.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized loss for fiscal 2025 was -$131.00M.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized loss for fiscal 2024 was -$190.00M, a 145.24% decline from fiscal 2023.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized loss for fiscal 2023 was $420.00M, a 137.29% increase from fiscal 2022.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized loss for fiscal 2022 was $177.00M, a 1164.29% increase from fiscal 2021.
| Period end | Debt Securities, Available-for-sale, Realized Loss 3 month | Debt Securities, Available-for-sale, Realized Loss 6 month | Debt Securities, Available-for-sale, Realized Loss 9 month | Debt Securities, Available-for-sale, Realized Loss 12 month | Debt Securities, Available-for-sale, Realized Loss 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $23.00M 10-Q · filed 2026-08-05 | $51.00M 10-Q · filed 2026-08-05 | -$194.00M derived: sum of 3 quarters · filed 2026-08-05 | -$167.00M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $28.00M 10-Q · filed 2026-05-06 | -$217.00M derived: sum of 2 quarters · filed 2026-05-06 | -$190.00M derived: sum of 3 quarters · filed 2026-05-06 | -$142.00M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | -$245.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$218.00M derived: sum of 2 quarters · filed 2026-02-10 | -$170.00M derived: sum of 3 quarters · filed 2026-08-05 | -$131.00M 10-K · filed 2026-02-10 | |
| 2025-09-30 | $27.00M 10-Q · filed 2025-10-29 | $75.00M derived: sum of 2 quarters · filed 2026-08-05 | $114.00M 10-Q · filed 2025-10-29 | -$238.00M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $48.00M 10-Q · filed 2026-08-05 | $87.00M 10-Q · filed 2026-08-05 | -$265.00M derived: sum of 3 quarters · filed 2026-08-05 | -$226.00M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $39.00M 10-Q · filed 2026-05-06 | -$313.00M derived: sum of 2 quarters · filed 2026-05-06 | -$274.00M derived: sum of 3 quarters · filed 2026-05-06 | -$203.00M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | -$352.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$313.00M derived: sum of 2 quarters · filed 2026-02-10 | -$242.00M derived: sum of 3 quarters · filed 2026-02-10 | -$190.00M 10-K · filed 2026-02-10 | |
| 2024-09-30 | $39.00M 10-Q · filed 2025-10-29 | $110.00M derived: sum of 2 quarters · filed 2025-10-29 | $162.00M 10-Q · filed 2025-10-29 | $288.00M derived: sum of 4 quarters · filed 2026-02-10 | |
| 2024-06-30 | $71.00M 10-Q · filed 2025-07-31 | $123.00M 10-Q · filed 2025-07-31 | $249.00M derived: sum of 3 quarters · filed 2026-02-10 | $359.00M derived: sum of 4 quarters · filed 2026-02-10 | |
| 2024-03-31 | $52.00M 10-Q · filed 2025-05-01 | $178.00M derived: sum of 2 quarters · filed 2026-02-10 | $288.00M derived: sum of 3 quarters · filed 2026-02-10 | $361.00M derived: sum of 4 quarters · filed 2026-02-10 | |
| 2023-12-31 | $126.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $236.00M derived: sum of 2 quarters · filed 2026-02-10 | $309.00M derived: sum of 3 quarters · filed 2026-02-10 | $420.00M 10-K · filed 2026-02-10 | |
| 2023-09-30 | $110.00M 10-Q · filed 2024-11-06 | $183.00M derived: sum of 2 quarters · filed 2024-11-06 | $294.00M 10-Q · filed 2024-11-06 | $336.00M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-06-30 | $73.00M 10-Q · filed 2024-08-07 | $184.00M 10-Q · filed 2024-08-07 | $226.00M derived: sum of 3 quarters · filed 2025-02-12 | $254.00M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-03-31 | $111.00M 10-Q · filed 2024-05-01 | $153.00M derived: sum of 2 quarters · filed 2025-02-12 | $181.00M derived: sum of 3 quarters · filed 2025-02-12 | $253.00M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2022-12-31 | $42.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $70.00M derived: sum of 2 quarters · filed 2025-02-12 | $142.00M derived: sum of 3 quarters · filed 2025-02-12 | $177.00M 10-K · filed 2025-02-12 | |
| 2022-09-30 | $28.00M 10-Q · filed 2023-11-01 | $100.00M derived: sum of 2 quarters · filed 2023-11-01 | $135.00M 10-Q · filed 2023-11-01 | $137.00M derived: sum of 4 quarters · filed 2024-02-07 | |
| 2022-06-30 | $72.00M 10-Q · filed 2023-08-02 | $107.00M 10-Q · filed 2023-08-02 | $109.00M derived: sum of 3 quarters · filed 2024-02-07 | $111.00M derived: sum of 4 quarters · filed 2024-02-07 | |
| 2022-03-31 | $35.00M 10-Q · filed 2023-05-03 | $37.00M derived: sum of 2 quarters · filed 2024-02-07 | $39.00M derived: sum of 3 quarters · filed 2024-02-07 | $40.00M derived: sum of 4 quarters · filed 2024-02-07 | |
| 2021-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $4.00M derived: sum of 2 quarters · filed 2024-02-07 | $5.00M derived: sum of 3 quarters · filed 2024-02-07 | $14.00M 10-K · filed 2024-02-07 | -$14.00M 10-K · filed 2022-02-09 |
| 2021-09-30 | $2.00M 10-Q · filed 2022-11-02 | $3.00M derived: sum of 2 quarters · filed 2022-11-02 | $12.00M 10-Q · filed 2022-11-02 | $15.00M derived: sum of 4 quarters · filed 2023-05-25 | |
| 2021-06-30 | $1.00M 10-Q · filed 2022-08-03 | $10.00M 10-Q · filed 2022-08-03 | $13.00M derived: sum of 3 quarters · filed 2023-05-25 | $16.00M derived: sum of 4 quarters · filed 2023-05-25 | |
| 2021-03-31 | $9.00M 10-Q · filed 2022-05-04 | $12.00M derived: sum of 2 quarters · filed 2023-05-25 | $15.00M derived: sum of 3 quarters · filed 2023-05-25 | $36.00M derived: sum of 4 quarters · filed 2023-05-25 | |
| 2020-12-31 | $3.00M derived: 8-K 12 month − 10-Q 9 month · filed 2023-05-25 | $6.00M derived: sum of 2 quarters · filed 2023-05-25 | $27.00M derived: sum of 3 quarters · filed 2023-05-25 | $62.00M 8-K · filed 2023-05-25 | -$62.00M 10-K · filed 2021-02-16 |
| 2020-09-30 | $3.00M 10-Q · filed 2021-11-03 | $24.00M derived: sum of 2 quarters · filed 2021-11-03 | $59.00M 10-Q · filed 2021-11-03 | $29.00M derived: sum of 4 quarters · filed 2022-02-09 | |
| 2020-06-30 | $21.00M 10-Q · filed 2021-08-04 | $56.00M 10-Q · filed 2021-08-04 | $26.00M derived: sum of 3 quarters · filed 2022-02-09 | $35.00M derived: sum of 4 quarters · filed 2022-02-09 | |
| 2020-03-31 | $35.00M 10-Q · filed 2021-05-04 | $5.00M derived: sum of 2 quarters · filed 2022-02-09 | $14.00M derived: sum of 3 quarters · filed 2022-02-09 | $16.00M derived: sum of 4 quarters · filed 2022-02-09 | |
| 2019-12-31 | -$30.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | -$21.00M derived: sum of 2 quarters · filed 2022-02-09 | -$19.00M derived: sum of 3 quarters · filed 2022-02-09 | -$17.00M 10-K · filed 2022-02-09 | $17.00M 10-K · filed 2020-02-18 |
| 2019-09-30 | $9.00M 10-Q · filed 2020-11-06 | $11.00M derived: sum of 2 quarters · filed 2020-11-06 | $13.00M 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $2.00M 10-Q · filed 2020-08-05 | $4.00M 10-Q · filed 2020-08-05 | |||
| 2019-03-31 | $2.00M 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | -$2.00M 10-K · filed 2021-02-16 | $2.00M 10-K · filed 2020-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |